ID   Rh18c
AC   CVCL_DG02
SY   RH18C
DR   cancercelllines; CVCL_DG02
DR   Cosmic; 1718357
DR   GEO; GSM186447
DR   GEO; GSM186448
DR   Progenetix; CVCL_DG02
DR   Wikidata; Q54950334
RX   PubMed=22142829;
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; 3819; FOXO1 + HGNC; 8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Derived from site: In situ; Perineus, muscle; UBERON=UBERON_0002379.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1659 ! Rh18
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
RX   PubMed=22142829; DOI=10.1158/1078-0432.CCR-11-2056;
RA   Shukla N., Ameur N., Yilmaz I., Nafa K., Lau C.-Y., Marchetti A.,
RA   Borsu L., Barr F.G., Ladanyi M.;
RT   "Oncogene mutation profiling of pediatric solid tumors reveals
RT   significant subsets of embryonal rhabdomyosarcoma and neuroblastoma
RT   with mutated genes in growth signaling pathways.";
RL   Clin. Cancer Res. 18:748-757(2012).
//